Case report Transient thyrotoxicosis following prolonged use of gonadotropin-releasing hormone agonist in women with endometriosis – a case report

In: Archives of Medical Science · 2008 · vol. 4(2) , pp. 200–203 · W2182647764
article OA: green CC0
📄 Open PDF View on OpenAlex

Abstract

This paper reports two cases showing transient thyrotoxicosis caused by prolonged use of gonadotropin-releasing hormone (GnRH) agonist. Case 1, a 31-year-old woman, was administered GnRH-agonist (leuprorelin acetate) for treatment of endometriosis. After four months she showed thyroid dysfunction. Case 2, a 43-year-old woman, who was previously diagnosed with chronic thyroiditis, was treated with GnRH-agonist (nafarelin acetate) for her endometriosis. Five months later, her thyroid functions worsened. After discontinuation of the GnRH-agonist, thyroid function of both cases recovered. In selected patients, who are on GnRH-agonist, attention to thyroid function is important.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (7)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK